Shares of Seaport Therapeutics Inc. are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol "SPTX" on May 1, 2026.
Seaport is a clinical-stage therapeutics company focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com